Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$157,085,941
+$30,259,755 QoQ
Shares Held
1,002,335
+20.7% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#26
of 1,603 holders
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LORD, ABBETT & CO. LLC holds $1,248,570,920 across 7 Drug Manufacturers - General names. NVS ranks #3 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
427,913 | $513,251,732 | |
| 2 | JNJ |
Johnson & Johnson
|
1,477,212 | $375,167,531 | |
| 3 | NVS |
Novartis AG
This page
|
1,002,335 | $157,085,941 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
929,682 | $117,456,023 | |
| 5 | ABBV |
AbbVie Inc.
|
180,108 | $45,322,377 | |
| 6 | BIIB |
Biogen Inc.
|
130,184 | $28,127,555 | |
| 7 | AZN |
Astrazeneca PLC
|
64,127 | $12,159,761 |
All Filings in NVS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $157,085,941 | 1,002,335 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $126,826,186 | 830,286 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $50,482,479 | 366,160 | Shares | Sole | 2026-02-13 | |
| 2020-03-31 | $50,758,858 | 615,632 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||